相似文献
1
Cervical Cancer Outcomes in Women With HIV in the Age of Antiretroviral Therapy.
JAMA Netw Open. 2025 Aug 1;8(8):e2527389. doi: 10.1001/jamanetworkopen.2025.27389.
2
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
Lancet HIV. 2018 Jan;5(1):e45-e58. doi: 10.1016/S2352-3018(17)30149-2. Epub 2017 Oct 26.
3
Cervical cancer screening uptake among women living with HIV in the era of universal test and treat policy in Malawi: results from the 2020-2021 Malawi population-based HIV impact assessment.
BMC Cancer. 2025 Jul 1;25(1):1052. doi: 10.1186/s12885-025-13436-1.
4
Highly active antiretroviral therapy (HAART) and outcome of cervical lesions and high-risk HPV in women living with HIV (WLHIV): A systematic review and meta-analysis.
Eur J Obstet Gynecol Reprod Biol. 2022 Nov;278:153-158. doi: 10.1016/j.ejogrb.2022.09.031. Epub 2022 Sep 30.
5
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
Cancer. 2024 Jul 15;130(14):2462-2471. doi: 10.1002/cncr.35289. Epub 2024 Mar 26.
6
Prevalence and risk factors of high-risk HPV and cervical abnormalities in HIV-positive women in Bali, Indonesia.
BMC Infect Dis. 2025 Mar 28;25(1):432. doi: 10.1186/s12879-025-10827-4.
7
Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: a modelling study.
Lancet Glob Health. 2025 Apr;13(4):e698-e706. doi: 10.1016/S2214-109X(24)00553-9.
8
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
9
A randomized clinical trial to assess the effectiveness of thermal ablation versus loop electrosurgical excision procedure for cervical cancer risk reduction in women living with HIV in Mozambique.
Int J Gynecol Cancer. 2025 Apr 26:101905. doi: 10.1016/j.ijgc.2025.101905.
10
Barriers and facilitators to the integration of cervical cancer screening and treatment service with antiretroviral therapy follow-up clinics for women living with HIV in Northwest Ethiopia: a qualitative study.
Front Public Health. 2025 Jun 19;13:1552524. doi: 10.3389/fpubh.2025.1552524. eCollection 2025.
本文引用的文献
1
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
Cancer. 2024 Jul 15;130(14):2462-2471. doi: 10.1002/cncr.35289. Epub 2024 Mar 26.
2
Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer.
AIDS. 2017 Feb 20;31(4):523-531. doi: 10.1097/QAD.0000000000001367.
3
HIV Infection and Survival Among Women With Cervical Cancer.
J Clin Oncol. 2016 Nov 1;34(31):3749-3757. doi: 10.1200/JCO.2016.67.9613.
4
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):405-13. doi: 10.1097/QAI.0b013e31828177d7.
5
Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa.
Cancer. 2012 Jun 1;118(11):2971-9. doi: 10.1002/cncr.26639. Epub 2011 Nov 9.
6
Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
AIDS. 2010 Oct 23;24(16):2553-61. doi: 10.1097/QAD.0b013e32833e163e.
Zotero 插件